159 related articles for article (PubMed ID: 36475496)
1. Adenovirus vector system: construction, history and therapeutic applications.
Syyam A; Nawaz A; Ijaz A; Sajjad U; Fazil A; Irfan S; Muzaffar A; Shahid M; Idrees M; Malik K; Afzal S
Biotechniques; 2022 Dec; 73(6):297-305. PubMed ID: 36475496
[TBL] [Abstract][Full Text] [Related]
2. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy.
Wang WC; Sayedahmed EE; Mittal SK
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560730
[TBL] [Abstract][Full Text] [Related]
3. Transduction of adenovirus vectors modified with cell-penetrating peptides.
Eto Y; Yoshioka Y; Asavatanabodee R; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
Peptides; 2009 Aug; 30(8):1548-52. PubMed ID: 19467282
[TBL] [Abstract][Full Text] [Related]
4. Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination.
Zhang W; Fu J; Ehrhardt A
Hum Gene Ther Methods; 2018 Jun; 29(3):124-134. PubMed ID: 29756505
[TBL] [Abstract][Full Text] [Related]
5. Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency.
Yoshioka Y; Asavatanabodee R; Eto Y; Watanabe H; Morishige T; Yao X; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
Life Sci; 2008 Nov; 83(21-22):747-55. PubMed ID: 18930744
[TBL] [Abstract][Full Text] [Related]
6. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenovirus vectors for gene therapy and clinical trials.
Nász I; Adám E
Acta Microbiol Immunol Hung; 2001; 48(3-4):323-48. PubMed ID: 11791337
[TBL] [Abstract][Full Text] [Related]
8. Current Use of Adenovirus Vectors and Their Production Methods.
Sayedahmed EE; Kumari R; Mittal SK
Methods Mol Biol; 2019; 1937():155-175. PubMed ID: 30706395
[TBL] [Abstract][Full Text] [Related]
9. Optimized PEGylated adenovirus vector reduces the anti-vector humoral immune response against adenovirus and induces a therapeutic effect against metastatic lung cancer.
Eto Y; Yoshioka Y; Ishida T; Yao X; Morishige T; Narimatsu S; Mizuguchi H; Mukai Y; Okada N; Kiwada H; Nakagawa S
Biol Pharm Bull; 2010; 33(9):1540-4. PubMed ID: 20823571
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel efficient method to construct an adenovirus library displaying random peptides on the fiber knob.
Yamamoto Y; Goto N; Miura K; Narumi K; Ohnami S; Uchida H; Miura Y; Yamamoto M; Aoki K
Mol Pharm; 2014 Mar; 11(3):1069-74. PubMed ID: 24380399
[TBL] [Abstract][Full Text] [Related]
11. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
Tang L; Gong M; Zhang P
Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
[TBL] [Abstract][Full Text] [Related]
12. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in genetic modification of adenovirus vectors for cancer treatment.
Yamamoto Y; Nagasato M; Yoshida T; Aoki K
Cancer Sci; 2017 May; 108(5):831-837. PubMed ID: 28266780
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy.
Wang Z; Zhang X
Cytotherapy; 2021 Dec; 23(12):1045-1052. PubMed ID: 34548241
[TBL] [Abstract][Full Text] [Related]
15. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
Jönsson F; Hagedorn C; Kreppel F
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
[TBL] [Abstract][Full Text] [Related]
16. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
17. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.
Krasnykh VN; Mikheeva GV; Douglas JT; Curiel DT
J Virol; 1996 Oct; 70(10):6839-46. PubMed ID: 8794325
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
[TBL] [Abstract][Full Text] [Related]
19. Respiratory muscles as a target for adenovirus-mediated gene therapy.
Petrof BJ
Eur Respir J; 1998 Feb; 11(2):492-7. PubMed ID: 9551759
[TBL] [Abstract][Full Text] [Related]
20. Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
Miura Y; Yoshida K; Nishimoto T; Hatanaka K; Ohnami S; Asaka M; Douglas JT; Curiel DT; Yoshida T; Aoki K
Gene Ther; 2007 Oct; 14(20):1448-60. PubMed ID: 17700705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
